Literature DB >> 21424160

Non-viral delivery of inductive and suppressive genes to adipose-derived stem cells for osteogenic differentiation.

Anusuya Ramasubramanian1, Stacey Shiigi, Gordon K Lee, Fan Yang.   

Abstract

PURPOSE: To assess the effects of co-delivering osteoinductive DNA and/or small interfering RNA in directing the osteogenic differentiation of human adipose-derived stem cells (hADSCs) using a combinatorial, non-viral gene delivery approach.
METHODS: hADSCs were transfected using combinations of the following genes: BMP2, siGNAS and siNoggin using poly(β-amino esters) or lipid-like molecules. A total of 15 groups were evaluated by varying DNA doses, timing of treatment, and combinations of signals. All groups were cultured in osteogenic medium for up to 37 days, and outcomes were measured using gene expression, biochemical assays, and histology.
RESULTS: Biomaterials-mediated gene delivery led to a dose-dependent up-regulation of BMP2 and significant gene silencing of GNAS and Noggin in hADSCs. BMP2 alone slightly up-regulates osteogenic marker expression in hADSCs. In contrast, co-delivery of BMP2 and siGNAS or siNoggin significantly accelerates the hADSC differentiation towards osteogenic differentiation, with marked increase in bone marker expression and mineralization.
CONCLUSIONS: We report a combinatorial platform for identifying synergistic interactions among multiple genetic signals associated with osteogenic differentiation of hADSCs. Our results suggest that inductive or suppressive genetic switches interact in a complex manner, and highlight the promise of combinatorial approaches towards rapidly identifying optimal signals for promoting desired stem cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424160     DOI: 10.1007/s11095-011-0406-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  39 in total

1.  Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells.

Authors:  Michela Aluigi; Miriam Fogli; Antonio Curti; Alessandro Isidori; Elisa Gruppioni; Claudia Chiodoni; Mario P Colombo; Piera Versura; Antonia D'Errico-Grigioni; Elisa Ferri; Michele Baccarani; Roberto M Lemoli
Journal:  Stem Cells       Date:  2005-08-11       Impact factor: 6.277

2.  Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo.

Authors:  Osamu Sugiyama; Dong Sung An; Sam P K Kung; Brian T Feeley; Seth Gamradt; Nancy Q Liu; Irvin S Y Chen; Jay R Lieberman
Journal:  Mol Ther       Date:  2005-03       Impact factor: 11.454

3.  Bone: formation by autoinduction.

Authors:  M R Urist
Journal:  Science       Date:  1965-11-12       Impact factor: 47.728

4.  Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex.

Authors:  C Banerjee; L R McCabe; J Y Choi; S W Hiebert; J L Stein; G S Stein; J B Lian
Journal:  J Cell Biochem       Date:  1997-07-01       Impact factor: 4.429

5.  In vivo bone formation following transplantation of human adipose-derived stromal cells that are not differentiated osteogenically.

Authors:  Oju Jeon; Jong Won Rhie; Il-Kuen Kwon; Jae-Hwan Kim; Byung-Soo Kim; Soo-Hong Lee
Journal:  Tissue Eng Part A       Date:  2008-08       Impact factor: 3.845

6.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.

Authors:  Akin Akinc; Andreas Zumbuehl; Michael Goldberg; Elizaveta S Leshchiner; Valentina Busini; Naushad Hossain; Sergio A Bacallado; David N Nguyen; Jason Fuller; Rene Alvarez; Anna Borodovsky; Todd Borland; Rainer Constien; Antonin de Fougerolles; J Robert Dorkin; K Narayanannair Jayaprakash; Muthusamy Jayaraman; Matthias John; Victor Koteliansky; Muthiah Manoharan; Lubomir Nechev; June Qin; Timothy Racie; Denitza Raitcheva; Kallanthottathil G Rajeev; Dinah W Y Sah; Jürgen Soutschek; Ivanka Toudjarska; Hans-Peter Vornlocher; Tracy S Zimmermann; Robert Langer; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2008-04-27       Impact factor: 54.908

7.  Lipid-like Nanoparticles for Small Interfering RNA Delivery to Endothelial Cells.

Authors:  Seung-Woo Cho; Michael Goldberg; Sun Mi Son; Qiaobing Xu; Fan Yang; Ying Mei; Said Bogatyrev; Robert Langer; Daniel G Anderson
Journal:  Adv Funct Mater       Date:  2009-08-25       Impact factor: 18.808

8.  A high-throughput siRNA library screen identifies osteogenic suppressors in human mesenchymal stem cells.

Authors:  Yuanxiang Zhao; Sheng Ding
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

9.  Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles.

Authors:  Fan Yang; Seung-Woo Cho; Sun Mi Son; Said R Bogatyrev; Deepika Singh; Jordan J Green; Ying Mei; Sohyun Park; Suk Ho Bhang; Byung-Soo Kim; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-05       Impact factor: 11.205

10.  Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells.

Authors:  Yoshikazu Mikami; Masatake Asano; Masaki J Honda; Minoru Takagi
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

View more
  12 in total

Review 1.  The roles of bone morphogenetic proteins and their signaling in the osteogenesis of adipose-derived stem cells.

Authors:  Xiao Zhang; Jing Guo; Yongsheng Zhou; Gang Wu
Journal:  Tissue Eng Part B Rev       Date:  2013-08-09       Impact factor: 6.389

Review 2.  Developing siRNA therapies to address osteoporosis.

Authors:  Yuwei Wang; David W Grainger
Journal:  Ther Deliv       Date:  2013-10

Review 3.  Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

Authors:  Nishant S Gandhi; Rakesh K Tekade; Mahavir B Chougule
Journal:  J Control Release       Date:  2014-09-07       Impact factor: 9.776

4.  Light-triggered RNA release and induction of hMSC osteogenesis via photodegradable, dual-crosslinked hydrogels.

Authors:  Cong Truc Huynh; Minh Khanh Nguyen; Mantas Naris; Gulen Yesilbag Tonga; Vincent M Rotello; Eben Alsberg
Journal:  Nanomedicine (Lond)       Date:  2016-06-01       Impact factor: 5.307

5.  Gene delivery of osteoinductive signals to a human fetal osteoblast cell line induces cell death in a dose-dependent manner.

Authors:  Anusuya Ramasubramanian; Shaheen Jeeawoody; Fan Yang
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

6.  Down-regulation of Noggin and miR-138 coordinately promote osteogenesis of mesenchymal stem cells.

Authors:  Xing-Kun Sun; Jin Zhou; Lei Zhang; Tian Ma; Yu-Han Wang; Yan-Mei Yang; Yan-Ting Tang; Hong Li; Li-Jun Wang
Journal:  J Mol Histol       Date:  2017-11-02       Impact factor: 2.611

7.  Photocrosslinkable, biodegradable hydrogels with controlled cell adhesivity for prolonged siRNA delivery to hMSCs to enhance their osteogenic differentiation.

Authors:  Minh Khanh Nguyen; Alexandra McMillan; Cong Truc Huynh; Daniel S Schapira; Eben Alsberg
Journal:  J Mater Chem B       Date:  2016-12-14       Impact factor: 6.331

8.  Spatial control of cell gene expression by siRNA gradients in biodegradable hydrogels.

Authors:  Michael C Hill; Minh K Nguyen; Oju Jeon; Eben Alsberg
Journal:  Adv Healthc Mater       Date:  2014-12-22       Impact factor: 9.933

9.  Adipose-derived stem cells and BMP-2 delivery in chitosan-based 3D constructs to enhance bone regeneration in a rat mandibular defect model.

Authors:  Jiabing Fan; Hyejin Park; Matthew K Lee; Olga Bezouglaia; Armita Fartash; Jinku Kim; Tara Aghaloo; Min Lee
Journal:  Tissue Eng Part A       Date:  2014-05-09       Impact factor: 3.845

10.  Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiation.

Authors:  Minh K Nguyen; Oju Jeon; Melissa D Krebs; Daniel Schapira; Eben Alsberg
Journal:  Biomaterials       Date:  2014-05-13       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.